Skip to content
OpenCapital
Get started

Silicon Laboratories SLAB Cash and cash equivalents used in net leverage ratio

Other financials

Income statement

See full
Revenue$213.5M+20.1%
Gross profit$127.0M+29.9%
Operating income-$17.1M+46.8%
Net income-$15.9M+47.8%
EPS (diluted)-$0.48+48.9%

Balance sheet

See full
Cash & equivalents$383.1M+17.9%
Total debt$24.0M+11.8%
Total equity$1.1B+2.8%
Total assets$1.3B+3.0%

Cash flow

See full
Operating cash flow$4.9M-89.7%
CapEx$9.8M+103%
Free cash flow-$4.9M-111%

Valuation

See full
Market cap$7.25B+113%
P/S8.8×+3.6×

Profitability

See full
Gross margin59.3%+5.1pp
Operating margin-6.8%-2.7pp
Net margin-6.1%-2.6pp
FCF margin-6.3%-21.8pp

Returns & leverage

See full
Return on equity-4.6%-1.9pp
Debt / equity0×0.0×
Current ratio5.1×-0.1×

Where this comes from

Reported directly by Silicon Laboratories in its filing.

Tagged under the XBRL concept slab:MaximumCashAndCashEquivalentsUsedInCalculatingNetLeverageRatio.

The official record: Silicon Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Silicon Laboratories's cash and cash equivalents used in net leverage ratio.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Silicon Laboratories's cash and cash equivalents used in net leverage ratio?
Silicon Laboratories (SLAB) reported cash and cash equivalents used in net leverage ratio of $750M in Q1 2026.
How has Silicon Laboratories's cash and cash equivalents used in net leverage ratio changed year-over-year?
Silicon Laboratories's cash and cash equivalents used in net leverage ratio decreased by 0.0% year-over-year, from $750M to $750M.